Clinical evaluation of two interferon-gamma release assay tests for immunocompromised patients

Y. Kobashi, M. Abe, K. Mouri, Y. Obase, N. Miyashita, M. Oka (Kurashiki, Japan)

Source: Annual Congress 2010 - Interferon-gamma releases assays (IGRAs) for the diagnosis of tuberculosis: what is the role?
Disease area: Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Kobashi, M. Abe, K. Mouri, Y. Obase, N. Miyashita, M. Oka (Kurashiki, Japan). Clinical evaluation of two interferon-gamma release assay tests for immunocompromised patients. Eur Respir J 2010; 36: Suppl. 54, 2150

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Clinical evaluation of interferon-gamma release assay (IGRA) in patients with nontuberculous mycobacterial disease
Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings
Year: 2012

The role of interferon-gamma release assays for the diagnosis of tuberculosis
Source: Annual Congress 2011 - TBNET: tuberculosis research in Europe
Year: 2011


Concordance between tuberculin skin testing and interferon-gamma release assays in diagnosis of latent tuberculosis infection among HIV-infected individuals
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Year: 2012

Serial interferon-gamma release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013

Utility of a T-cell interferon-gamma release assay for the diagnosis of tuberculous serositis: A prospective study in Beijing, China
Source: Annual Congress 2013 –Diagnostic features of tuberculosis I
Year: 2013


Use of tuberculin skin test, IFN-gamma release assays and IFN-gamma-induced protein-10 to identify children with TB infection
Source: Eur Respir J 2013; 41: 644-648
Year: 2013



Comparison of whole-blood interferon-gamma release assay and tuberculin skin test results for the prediction of active tuberculosis disease in HIV-infected individuals
Source: Annual Congress 2009 - Tuberculosis and HIV co-infection
Year: 2009


Serial interferon-gamma release assay in children with tuberculosis infection
Source: Annual Congress 2010 - Tuberculosis in children
Year: 2010

Comparative study of the usefulness of TST and three interferon-gamma release assasys (IGRAs) for the differential diagnosis of pulmonary tuberculosis
Source: Annual Congress 2011 - Tuberculin skin tests, interferon-gamma release assays and beyond
Year: 2011

Update: T-cell interferon-gamma release assays for the diagnosis of MTB infection
Source: Annual Congress 2008 - PG20 - Advances in the diagnosis of Mycobacterium tuberculosis infection: an interactive, case-based course
Year: 2008



Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis
Source: Eur Respir J 2008; 32: 1607-1615
Year: 2008



Use of interferon-gamma release assays in diagnosis of active TB infection - Experience of a rural UK hospital
Source: Annual Congress 2013 –Tuberculosis diagnosis
Year: 2013


Use of an ELISPOT interferon-gamma release assay for screening of end-stage renal failure contacts in haemodialysis centres
Source: International Congress 2014 – Tuberculosis: from diagnosis to therapy and prevention
Year: 2014

Diagnosis of tuberculosis: principles and practice of using Interferon-gamma release assays (IGRAs)
Source: Breathe 2009; 5: 302-309
Year: 2009

Diagnostic performance of the interferon gamma release assay in elderly patients and clinical factors to support the diagnosis of active tuberculosis
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Year: 2012

Performance of two interferon-gamma release assays (T-SPOT.TB and QuantiFERON-TB GOLD In Tube) increase diagnostic yield of tuberculin skin testing for detection of latent tuberculosis in patients with inflammatory bowel disease
Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts
Year: 2011


Concordance between tuberculin skin test and interferon-gamma release assay in Mycobacterium tuberculosis infected children aged up to five years
Source: Annual Congress 2010 - Clinical tuberculosis
Year: 2010

Support of ex vivo IFN-gamma release assays in the diagnosis of tuberculosis infection in HIV/AIDS patients
Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Year: 2008


Discordance between tuberculin skin tests (TST) and interferon gamma release assays (IGRAs): Are we over-treating LTBI?
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018




Clinical utility of pleural fluid interferon-gamma release assay in tuberculous pleurisy diagnosis
Source: International Congress 2017 – Microbiology and laboratory techniques to monitor NTM infections
Year: 2017